Silo Pharma, Inc.: Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment
Silo Pharma, Inc. (Nasdaq: SILO) ("Silo" or the "Company"), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery ...
greenmarketreport58m
Compass Pathways goes further in the red in 2024 as trial results loom
The biotech firm expects top-line data for COMP360 next quarter following October's restructuring and last month's fresh ...